The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs-Reference-Cited by-同舟云学术

The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs

Author:

Park Heung-Woo¹²^ORCID,Kim Sang-Heon³,Chang Yoon-Seok⁴,Kim Sang-Hoon⁵,Jee Young-Koo⁶,Lee Ai-Young⁷,Jang In-Jin⁸,Park Hae-Sim⁹^ORCID,Min Kyung-Up¹²

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

2. Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea.

3. Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

4. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

5. Department of Internal Medicine, Eulji University School of Medicine, Daejeon, Korea.

6. Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.

7. Department of Dermatology, Dongguk University Ilsan Hospital, Goyang, Korea.

8. Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, Seoul, Korea.

9. Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.

Publisher

The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al

Subject

Pulmonary and Respiratory Medicine,Immunology,Immunology and Allergy

Link

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献